Immune Stimulatory Oligoribonucleotide Analogs Containing Modified Oligophosphate Moieties

Patent No. EP2207787 (titled "Immune Stimulatory Oligoribonucleotide Analogs Containing Modified Oligophosphate Moieties") was filed by Adiutide Pharmaceuticals on Oct 30, 2008. The application was issued on Nov 12, 2014.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
RIGONTEC GMBHAug 10, 2015WICHMANN

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2207787

ADIUTIDE PHARMACEUTICALS
Application Number
EP08847550A
Filing Date
Oct 30, 2008
Status
Revoked
Jan 18, 2019
Publication Date
Nov 12, 2014